TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis

Summary Regulation of metabolic pathways plays an important role in controlling cell growth, proliferation, and survival. TIGAR acts as a fructose-2,6-bisphosphatase, potentially promoting the pentose phosphate pathway to produce NADPH for antioxidant function and ribose-5-phosphate for nucleotide synthesis. The functions of TIGAR were dispensable for normal growth and development in mice but played a key role in allowing intestinal regeneration in vivo and in ex vivo cultures, where growth defects due to lack of TIGAR were rescued by ROS scavengers and nucleosides. In a mouse intestinal adenoma model, TIGAR deficiency decreased tumor burden and increased survival, while elevated expression of TIGAR in human colon tumors suggested that deregulated TIGAR supports cancer progression. Our study demonstrates the importance of TIGAR in regulating metabolism for regeneration and cancer development and identifies TIGAR as a potential therapeutic target in diseases such as ulcerative colitis and intestinal cancer.

[1]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[2]  E. Schon,et al.  Analysis of mouse models of cytochrome c oxidase deficiency owing to mutations in Sco2. , 2010, Human molecular genetics.

[3]  J. Steinbach,et al.  Tp53-induced Glycolysis and Apoptosis Regulator (TIGAR) Protects Glioma Cells from Starvation-induced Cell Death by Up-regulating Respiration and Improving Cellular Redox Homeostasis* , 2012, The Journal of Biological Chemistry.

[4]  D. Winton,et al.  Target cells for the cytotoxic effects of carcinogens in the murine small bowel. , 1992, Carcinogenesis.

[5]  G. Riggins,et al.  Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2 , 2012, Current opinion in oncology.

[6]  Ian P Newton,et al.  Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. , 2004, Genes & development.

[7]  Hanna Y. Irie,et al.  Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment , 2009, Nature.

[8]  Jinsong Liu,et al.  Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. , 2006, Cancer cell.

[9]  C. Thompson,et al.  Glutamine addiction: a new therapeutic target in cancer. , 2010, Trends in biochemical sciences.

[10]  Ralph J Deberardinis,et al.  Brick by brick: metabolism and tumor cell growth. , 2008, Current opinion in genetics & development.

[11]  R. Jaenisch,et al.  A transgenic mouse strain expressing four drug-selectable marker genes. , 1997, Nucleic acids research.

[12]  M. Murphy,et al.  Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. , 2012, Antioxidants & redox signaling.

[13]  H. Clevers,et al.  Identification of stem cells in small intestine and colon by marker gene Lgr5 , 2007, Nature.

[14]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[15]  Hans Clevers,et al.  Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.

[16]  E. White,et al.  Immortalized mouse epithelial cell models to study the role of apoptosis in cancer. , 2008, Methods in enzymology.

[17]  Reynaldo Sequerra,et al.  High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP , 2000, Nature Genetics.

[18]  V. Costanzo,et al.  ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair , 2010, The EMBO journal.

[19]  D. Albertson,et al.  Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability , 2005, Nature.

[20]  J. López-Barneo,et al.  The Mitochondrial SDHD Gene Is Required for Early Embryogenesis, and Its Partial Deficiency Results in Persistent Carotid Body Glomus Cell Activation with Full Responsiveness to Hypoxia , 2004, Molecular and Cellular Biology.

[21]  H. Cooper,et al.  Clinicopathologic study of dextran sulfate sodium experimental murine colitis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[22]  O. Sansom,et al.  Inhibition of CXCR2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. , 2012, The Journal of clinical investigation.

[23]  K. Vousden,et al.  Mitochondrial localization of TIGAR under hypoxia stimulates HK2 and lowers ROS and cell death , 2012, Proceedings of the National Academy of Sciences.

[24]  Hans Clevers,et al.  Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. , 2011, Gastroenterology.

[25]  Scott E. Kern,et al.  Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis , 2011, Nature.

[26]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[27]  C. Nathan,et al.  Production of large amounts of hydrogen peroxide by human tumor cells. , 1991, Cancer research.

[28]  R. Hamanaka,et al.  Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. , 2010, Trends in biochemical sciences.

[29]  L. Yin,et al.  Inhibition of the MUC1-C oncoprotein induces multiple myeloma cell death by down-regulating TIGAR expression and depleting NADPH. , 2012, Blood.

[30]  C. Potten,et al.  Apoptosis in small intestinal epithelia from p53-null mice: evidence for a delayed, p53-indepdendent G2/M-associated cell death after γ-irradiation , 1997, Oncogene.

[31]  C. Thompson,et al.  The molecular determinants of de novo nucleotide biosynthesis in cancer cells. , 2009, Current opinion in genetics & development.

[32]  L. Nutt,et al.  Results Inhibition of NADPH production through the pentose phosphate pathway triggers apoptosis in Drosophila S 2 cells , 2010 .

[33]  Gerald C. Chu,et al.  Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.

[34]  N. Copeland,et al.  A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.

[35]  B. Faubert,et al.  Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. , 2011, Genes & development.

[36]  K. Vousden,et al.  p53: new roles in metabolism. , 2007, Trends in cell biology.

[37]  Chi V Dang,et al.  Links between metabolism and cancer. , 2012, Genes & development.

[38]  G. Reifenberger,et al.  RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival , 2012, Oncogene.

[39]  Julie A. Wilkins,et al.  Focal adhesion kinase is required for intestinal regeneration and tumorigenesis downstream of Wnt/c-Myc signaling. , 2010, Developmental cell.

[40]  Youn Wha Kim,et al.  Regulatory role of p53 in cancer metabolism via SCO2 and TIGAR in human breast cancer. , 2012, Human pathology.

[41]  Alison Martin,et al.  Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. , 2007, Cancer cell.

[42]  J. Rogers,et al.  A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction. , 2005, Genomics.

[43]  Hans Clevers,et al.  OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. , 2009, Gastroenterology.

[44]  T. Van Loy,et al.  Lgr4 is required for Paneth cell differentiation and maintenance of intestinal stem cells ex vivo , 2011, EMBO reports.

[45]  Gavin Kelly,et al.  Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival. , 2012, Cancer discovery.

[46]  J. Rabinowitz,et al.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation , 2012, Proceedings of the National Academy of Sciences.

[47]  Hua Li,et al.  Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)* , 2009, Journal of Biological Chemistry.

[48]  A. Bradley,et al.  Null and conditional semaphorin 3B alleles using a flexible puroΔtk loxP/FRT vector , 2005, Genesis.

[49]  Kevin M. Ryan,et al.  p53 and metabolism , 2009, Nature Reviews Cancer.

[50]  Jason W. Locasale,et al.  Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses , 2011, Science.

[51]  Guido Kroemer,et al.  Tumor cell metabolism: cancer's Achilles' heel. , 2008, Cancer cell.

[52]  T. Mak,et al.  Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.

[53]  H. Clevers,et al.  Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche , 2009, Nature.

[54]  E. Koonin,et al.  Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD , 2004, Science.

[55]  A. Levine,et al.  Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway , 2012, Cell.

[56]  Wei Gu,et al.  Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence , 2012, Cell.

[57]  K. Vousden,et al.  Modulation of intracellular ROS levels by TIGAR controls autophagy , 2009, The EMBO journal.

[58]  Gregory Stephanopoulos,et al.  Amplification of phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis , 2012, BMC Proceedings.

[59]  Gong Yang,et al.  Mitochondrial Manganese-Superoxide Dismutase Expression in Ovarian Cancer , 2005, Journal of Biological Chemistry.

[60]  R. Frenkel.  Regulation and physiological functions of malic enzymes. , 1975, Current topics in cellular regulation.